论文部分内容阅读
1982年11月～1984年11月,我们对23例由化疗药物引起中毒性肝炎的绒毛膜上皮癌(绒癌)患者(其中2例同时 HBsAg 阳性)采用联苯双酯治疗,并选择条件相似而采用一般保肝药物治疗的23例(其中2例同时 HBsAg 阳性)作为对照。现将结果报告如下。一般资料联苯双酯组:年龄18～35岁。病种:绒癌Ⅰ期及Ⅱ期3例,Ⅲ期及Ⅵ期17例,恶性葡萄胎3例。化疗药物:5-氟脲嘧啶(5-Fu)加消瘤芥
From November 1982 to November 1984, 23 patients with choriocarcinoma (choriocarcinoma) with toxic hepatitis induced by chemotherapeutic drugs (2 of them with positive HBsAg at the same time) were treated with bifendate and selected at similar conditions Twenty-three patients (2 of whom were HBsAg-positive at the same time) were treated with general hepatoprotective drug as a control. The results reported below. General information Bifendate group: aged 18 to 35 years old. Disease: choriocarcinoma Ⅰ and Ⅱ in 3 cases, Ⅲ and Ⅳ in 17 cases, 3 cases of malignant mole. Chemotherapy drugs: 5-fluorouracil (5-Fu) plus tumor mustard